Recombinant HSV-8 M
Beta LifeScience
SKU/CAT #: BLIT-0925
Recombinant HSV-8 M
Beta LifeScience
SKU/CAT #: BLIT-0925
Our products are highly customizable to meet your specific needs. You can choose options such as endotoxin removal, liquid or lyophilized forms, preferred tags, and the desired functional sequence range for proteins. Submitting a written inquiry expedites the quoting process.
Product Overview
Tag | N/A |
Host Species | HSV-8 |
Background | Entry of HSV into the host cell involves interactions of several viral glycoproteins with cell surface receptors. The virus particle is covered by an envelope which, when bound to specific receptors on the cell surface, will fuse with the cell membrane and create an opening, or pore, through which the virus enters the host cell. The sequential stages of HSV entry are analagous to those of other viruses. At first, complementary receptors on the virus and cell surface bring the two membranes into proximity. In an intermediate state, the two membranes begin to merge, forming a hemifusion state. Finally, a stable entry pore is formed through which the viral envelope contents are introduced to the host cell. |
Description | The E.Coli derived recombinant protein contains the C-terminal immunodominant regions from ORF65 140-170 a.a. and N-terminal regions from ORF8 32-62 a.a. The protein is fused with a GST tag. |
Source | E.coli |
Purity | HSV-8 Mosaic protein is >95% pure as determined by 10% PAGE (coomassie staining). |
Formulation | 100mM NaCl, 0.1% SDS and 50% glycerol. |
Applications | Antibody ELISA; immunogen; WB, etc. |
Usage | For Research Use Only |